-
EXPEDITED REGULATORY PATHWAYS AND REIMBURSEMENT DECISIONS FOR INNOVATIVE CANCER DRUGS IN CHINA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
Mar 18, 2026, 21:38 PM -
AN EXPANDED ANALYSIS OF WHICH FEATURES CONVEY EMPATHY TO PATIENTS IN SCIENTIFIC WRITING
Mar 18, 2026, 21:38 PM -
IMPACT OF MEDICATION ADHERENCE ON CLINICAL AND ECONOMIC OUTCOMES IN TYPE 2 DIABETES: A SCOPING REVIEW OF REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION ANALYSIS OF DAMOCTOCOG ALFA PEGOL VERSUS EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS IN COLOMBIA, PERU AND COSTA RICA
Mar 18, 2026, 21:38 PM -
ARCHITECTURE OF RARE-DISEASE MODELS: STRUCTURAL CHOICES AND CLINICAL TRIAL ENDPOINT USE IN NICE HST EVALUATIONS
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS OF HOSPITAL-ONSET METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS IN U.S. HOSPITALS: 2023-2025
Mar 18, 2026, 21:38 PM -
TARGETED REVIEW FOR OUTCOME-BASED CONTRACTING FRAMEWORKS
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING OPEN HEART VALVE REPLACEMENT: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
EFFICACY OF CAR T-CELL THERAPY IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS OF RECURRENT STROKES IN MEDICARE FEE-FOR-SERVICE BENEFICIARIES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
ASSESSING SOCIAL MEDIA SENTIMENT TO ANALYZE PATIENT, CAREGIVER AND HEALTHCARE PROFESSIONALS EXPERIENCE WITH IMMUNOGLOBULIN (IVIG AND SCIG) FOR CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY (CIDP)
Mar 18, 2026, 21:38 PM -
DRG VARIATION IN LENGTH OF STAY AND POTENTIAL AVOIDABLE BED-DAYS: EVIDENCE FROM ROMANIA, 2023
Mar 18, 2026, 21:38 PM -
A COMPREHENSIVE SYSTEMATIC LITERATURE REVIEW OF MERKEL CELL CARCINOMA EPIDEMIOLOGY IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
APPLICATION OF THE ELEVATE-GENAI FRAMEWORK TO AN AI AGENTIC SYSTEM FOR DATA ANALYTICS
Mar 18, 2026, 21:38 PM -
AN AGENTIC AI FRAMEWORK INTEGRATING DATA-DRIVEN HYPOTHESIS GENERATION WITH TRADITIONAL VALIDATION FOR REAL-WORLD EVALUATION OF EMERGING THERAPIES
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS, OUTCOMES, HCRU AND COSTS ASSOCIATED WITH PREVIOUSLY-TREATED EXTENSIVE-STAGE SCLC IN THE US FOLLOWING THE APPROVAL OF NEWER TREATMENT OPTIONS
Mar 18, 2026, 21:38 PM -
A METHODOLOGICAL REVIEW OF VALUATION STUDIES FOR THE EQ-5D-5L: EVOLVING PRACTICES AND LESSONS FROM THE EQ-5D-3L
Mar 18, 2026, 21:38 PM -
DRG-BASED DIFFUSION OF DAY SURGERY IN HUNGARY: CASE-GROUP AND PROVIDER VARIATION
Mar 18, 2026, 21:38 PM -
PATIENT SUPPORT AND REAL-WORLD EVIDENCE GENERATION IN RARE DISEASE: A CASE STUDY IN HYPOPHOSPHATASIA
Mar 18, 2026, 21:38 PM
